The calmodulin (CaM) inhibitor trifluoperazine (TFP) can produce analgesia when given intrathecally to rats, however the mechanism is not known. We asked whether TFP could modulate the Na v 1.7 sodium channel, which is highly expressed in the peripheral nervous system and plays an important role in nociception. We show that 500 nM and 2 µM TFP induce major decreases in Na v 1.7 and Na v 1.4 current amplitudes and that 2 µM TFP causes hyperpolarizing shifts in the steady-state inactivation of Na v 1.7
Introduction
Previous research has demonstrated that intrathecal administration of trifluoperazine (TFP) has analgesic effects at low doses (Golbidi, et al., 2002) . However, it is not clear how TFP is able to induce analgesia. TFP is one of the most potent calmodulin (CaM) inhibitors among the phenothiazine neuroleptics (Brostrom and Wolff, 1981; Levin and Weiss, 1979) . CaM, a 16.7 kDa protein that is expressed in virtually all eukaryotic cells, can bind calcium and induce changes in target proteins. Several studies indicate that CaM can bind to and alter the activity of voltage-gated sodium channels (Deschenes, et al., 2002; Tan, et al., 2002) and we previously showed that CaM can modulate Na v 1.4 (skeletal muscle) and Na v 1.6 (neuronal) current amplitudes and properties (Herzog, et al., 2003) . TFP is also able to reduce peak sodium current in a concentration-dependent manner in giant squid axons (Ichikawa, et al., 1991) . These studies raise the possibility that TFP could exert its analgesic effects by modulating sodium currents in mammalian neurons and that this might involve disruption of the CaM-channel interaction.
Alterations in sodium currents within the peripheral nervous system can contribute to changes in cellular excitability and are likely to play important roles in nociception. The predominant sodium channel isoforms in nociceptive neurons are Na v 1.7, Na v 1.8, and Na v 1.9. Although the C-terminal region of sodium channels that contains the CaM binding motif is well conserved, our previous results indicated that the C-terminus of Na v 1.8 and Na v 1.9 do not appreciably bind CaM (Herzog et al., 2003) .
The C-terminus of Na v 1.7 does bind CaM, although it has a lower apparent affinity than the C-termini of other TTX-sensitive isoforms. Na v 1.7 (also referred to as PN1) is Page 3 of 50 expressed at high levels in the peripheral nervous system (Sangameswaran, et al., 1997; Toledo-Aral, et al., 1997) and deletion of the mouse Na v 1.7 gene in a subset of sensory neurons that are predominantly nociceptive decreases responses to noxious mechanostimulation and induced inflammatory pain (Nassar, et al., 2004) . Furthermore, it has been recently reported that patients with a painful inherited neuropathy, primary erythermalgia, have mutations in their Na v 1.7 channels that cause significant hyperpolarizing shifts in the channel V 1/2 of activation as well as larger ramp currents (Cummins, et al., 2004; Yang, et al., 2004) . Because of its important role in nociception, modulation of Na v 1.7 currents could be a factor in the analgesic effects of TFP.
Although sodium channels are subject to extensive modulation, little is known about modulation of Na v 1.7. It has been recently reported that Na v 1.7 expressed in Xenopus oocytes can be modulated by protein kinase A and protein kinase C (Vijayaragavan, et al., 2004) . However, it is not known if CaM, or CaM antagonists, can modulate Na v 1.7 currents. The goal of the present study was to investigate if TFP can modulate Na v 1.7 current and if this modulation was due to inhibition of the channel interaction with CaM. As our previous results indicated that Na v 1.7 had a lower affinity for CaM than Na v 1.4 channels (Herzog et al., 2003) , we predicted that if TFP could modulate Na v 1.7 current by altering the interaction with CaM, then TFP would have dissimilar effects on Na v 1.4 and Na v 1.7. Understanding the effects of TFP on Na v 1.7 could lead to a better understanding the drug's analgesic properties and possible use in regional anesthesia and thus pain management. with 10% fetal bovine serum. Transfections of Na v 1.4 and Na v 1.7 were performed using the calcium phosphate precipitation technique. No I subunits were transfected with the channels as previous studies have shown that I subunits do not alter the effect of CaM on sodium currents in HEK293 cells (Deschênes et al., 2002; Young and Caldwell, 2005) .
The calcium phosphate-DNA mixture was added to the cell culture medium and left for 15-20 hr, after which time the cells were washed with fresh medium. After 48 hours, antibiotic (G418, Geneticin; Cellgro, Herndon, VA) was added to select for neomycinresistant cells. After 2-3 weeks in G418, colonies were picked, split, and subsequently tested for channel expression using whole-cell patch-clamp recording techniques.
Chemicals and Solutions. For application during voltage-clamp experiments, TFP
(Sigma Aldrich Co., St. Louis, MO) was dissolved in sterile water to give stock solutions of 10 mM and 300 µM, respectively. Calmodulin inhibitory peptide (EMD Biosciences, Inc., San Diego, CA) was dissolved in sterile water to give a stock solution of 240 µM.
Lidocaine hydrochloride was purchased from Sigma Aldrich Co., St. Louis, MO. For the sciatic nerve blockade, TFP at 10, 20, 40 and 80 mM and lidocaine at 40 mM were dissolved in 0.9% sodium chloride shortly before the experiments. Upon local injection, the relatively low pH of these solutions (pH range, 3.9-6.0) is likely to be buffered quickly by the tissue fluid, which has a pH of 7.4.
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Whole Cell Patch-Clamp Recordings. Whole cell patch-clamp recordings were conducted at room temperature (~21 o C) using a HEKA EPC-10 double amplifier. Data were acquired on a Windows-based Pentium IV computer using the Pulse program (v 8.65, HEKA Electronic, Germany). Fire-polished electrodes (0.9-1.3 MM) were fabricated from 1.7 mm capillary glass using a Sutter P-97 puller (Novato, CA, USA).
The standard pipette solution contained (in mM): 140 CsF, 10 NaCl, 1.1 EGTA, and 10 HEPES, pH 7.3. The pipette solution used for the calmodulin inhibitory peptide experiments contained (in mM): 90 CsF, 10 BAPTA, 10 NaCl, 10 HEPES, pH 7.3.
CsOH was used to adjust pH for the pipette solutions. The standard bathing solution contained (in mM): 140 NaCl, 1 MgCl 2 , 3 KCl, 1 CaCl 2 , and 10 HEPES, pH 7.3 (adjusted with NaOH). Series resistance errors were compensated to be less than 3 mV.
Subfascial Sciatic Nerve Injections. The protocol for animal experimentation was reviewed and approved by the Harvard Medical Area Standing Committee on Animals (Boston, MA, USA). Female Sprague-Dawley rats were purchased from Charles River Laboratory (Wilmington, MA) and kept in the animal housing facilities at Brigham and Women's Hospital, with controlled relative humidity (20% -30%), at room temperature (24°C), and in a 12-hour (6:00 AM -6:00 PM) light-dark cycle. Rats were handled before the procedure to familiarize them with the experimental environment and to minimize stress-induced analgesia. At the time of injections, animals weighed 200-250 grams and showed no signs of neurobehavioral impairment. The experimenter was blinded to the drug and concentration used. After rats were anesthetized by inhalation of 1-2% isoflurane, the sciatic nerves were exposed by lateral incision of the thighs and Page 6 of 50 6 division of the superficial fascia and muscle. 0.2 mL of the test dose was injected directly beneath the clear fascia surrounding the nerve but outside the perineurium, proximal to the sciatic bifurcation, with a 30-G needle attached to a tuberculin syringe.
The test doses comprised of TFP at concentrations from 10 to 80 mM, lidocaine at 40 mM as active control, and normal saline (vehicle only), n=8 per group. The superficial muscle layer was sutured with 4-0 silk, and the wound was closed as described (Kalichman, et al., 1989) Neurobehavioral Examination. The neurobehavioral examination, modified from earlier reports, (Thalhammer, et al., 1995) focused on motor and sensory function.
Initially, rats were examined at 30 minutes and 1 hour after drug administration, then at 1-hour intervals until 3 hours, and at 6, 12, 24 and 48 hours. Briefly, we evaluated motor function by measuring the extensor postural thrust of the hind limbs by holding the rat upright with the hind limb extended so that the distal metatarsus and toes support the animal's weight, thereby measuring the extensor thrust as the gram force applied to a digital platform balance (Ohaus Lopro, Fisher Scientific, Florham Park, NJ) . The reduction in this force, representing reduced extensor muscle contraction due to motor blockade, was calculated as a percentage of the control force (preinjection control value range was 125 to155 grams). The percentage value was assigned a score: 0 = no block or baseline; 1 = minimal block, force between 100% and 50% of preinjection control value; 2 = moderate block; force between 50% of the preinjection control value and 20 grams (~20 grams is the weight of the flaccid limb); 3 = complete block, force equal to or less than 20 grams.
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7 Sensory function (pain withdrawal) was evaluated by the withdrawal reflex or vocalization to pinch of a skin fold over the lateral metatarsus (cutaneous pain) and of the distal phalanx of the fifth toe (deep pain). This nocifensive reaction was graded in the following manner on a scale of 0-3 and based on withdrawal reflex, escape behavior, and vocalization: 0 (baseline or normal, brisk withdrawal reflex, normal escape behavior and strong vocalization), 1 (mildly impaired), 2 (moderately impaired), and 3 (totally impaired nocifensive reaction). We repeated the examination three times; the average was used.
Data Analysis. Voltage-clamp experimental data were analyzed using the Pulsefit (v 8.65, HEKA Electronic, Germany) and Origin (OriginLab Corp., Northhampton, MA, USA) software programs. Slope factors of steady-state inactivation curves were calculated using the general Boltzmann function: I(V) = Offset + (Amplitude/1 + exp(-(V-V half )/Slope). Two-way analysis of variance (ANOVA) was applied to test for differences in motor sciatic nerve block duration and sensory block duration between 4 different doses of TFP and 40 mM lidocaine. A significant F-test was followed by multiple pairwise group comparisons using the post-hoc Tukey procedure. To protect against Type I errors (false positives), a power analysis indicated that the sample size of eight animals per group provided 80% statistical power ( = 0.2, 2-tailed = 0.05) to detect significant differences in block duration using ANOVA among the four doses of TFP and in the TFP versus lidocaine comparison (version 6.0, nQuery Advisor, Statistical Solutions, Boston, MA). We presented the data in all figures in terms of the mean and SEM because we tested the data at each dose within the drug groups for normality using Na v 1.7 showed decreases in peak sodium currents of 19.4 ± 6.0 % (n = 6) and 76.7 ± 4.6 % (n = 6) after approximately 2.5 minutes during application of 500 nM and 2 µM TFP, respectively. Under the same conditions the same two concentrations of TFP produced decreases in peak Na v 1.4 currents of 14.7 ± 7.3 % (n = 6) and 59.4 ± 7.8 % (n = 5), respectively. TFP Causes Hyperpolarizing Shifts in Na v 1.7 and Na v 1.4 Steady-State Inactivation. To understand how TFP reduces sodium current amplitude we investigated the effect of TFP on steady-state inactivation. We observed that application of 500 nM and 2 µM TFP to cells containing Na v 1.7 caused hyperpolarizing shifts of -5.0 ± 0.87 mV (n = 6) and -18.4 ± 2.3 mV (n = 6) in the V 1/2 of steady-state inactivation, respectively (Fig. 2, A and B) , where V 1/2 was determined by fitting the data with the standard Boltzmann function as shown in Methods. The slope factor of the steady-state Page 10 of 50 inactivation curve for Na v 1.7 in the absence of TFP was 6.6 ± 0.1. Following application of 500 nM and 2 µM TFP the slope factors were 7.0 ± 0.3 and 10.2 ± 0.5, respectively.
Application of the same two concentrations of TFP to cells containing Na v 1.4 caused hyperpolarizing shifts in the V 1/2 of steady-state inactivation of -5.0 ± 0.87 mV (n = 5) and -11.4 ± 0.80 mV (n = 6), respectively (Fig. 2, D and E). The slope factor of the steady-state inactivation curve for Na v 1.4 in the absence of TFP was 6.0 ± 0.1.
Following application of 500 nM and 2 µM TFP the slopes were 5.9 ± 0.1 and 6.6 ± 0.3, respectively. In control experiments (without TFP application) time-dependent shifts were observed in the V 1/2 of steady-state inactivation taken 7 minutes apart for Na v 1.7 channels (-2.6 ± 0.43 mV; n = 6) and Na v 1.4 channels (-4.7 ± 1.1 mV; n = 5). Thus, application of 500 nM TFP did not cause a significant hyperpolarizing shift in the V 1/2 of steady-state inactivation of Na v 1.7 or Na v 1.4 compared to the hyperpolarizing shift that was observed in these channels over the same period of time in control experiments.
However, 2 µM TFP did cause a significant hyperpolarizing shift in the V 1/2 of steadystate inactivation of Na v 1.7 channels and Na v 1.4 channels compared to time-dependent controls ( (right) for both Na v 1.7 and Na v 1.4. In the presence of 500 nM TFP, there were 67.6 ± 3.3 % (n = 6) and 54.1 ± 6.7 % (n = 5) decreases from the current amplitudes evoked by the first pulse to the current amplitudes evoked by the last pulse in the protocol for Na v 1.7
and Na v 1.4, respectively. In the presence of 2 µM TFP decreases of 73.8 ± 5.6 % (n = 6) and 80.4 ± 3.4 % (n = 6) were observed for Na v 1.7 and Na v 1.4, respectively. All of these decreases in peak current amplitudes were significant compared to time-dependent decreases in peak current amplitudes in the absence of drug ( (Torok, et al., 1998) . This inhibitor is not cell permeable and had to be added directly to the pipette solution. Recordings were taken 12 minutes after obtaining wholecell configuration to allow for adequate diffusion of the peptide into the cell.
Changes in steady-state inactivation of Na v 1.7 were observed in the presence of 1 µM calmodulin inhibitory peptide (Fig. 4A ). The mean V 1/2 of steady-state inactivation of Na v 1.7 in the presence of 1 µM calmodulin inhibitory peptide was significantly hyperpolarized compared to without the peptide (Fig. 4C ). In contrast, steady-state inactivation of Na v 1.4 was unaffected by the presence of 1 µM calmodulin inhibitory peptide (Fig. 4B) . Although there is a small difference, the mean V 1/2 of inactivation of Na v 1.4 in the presence and absence of the peptide were not statistically different ( Fig. Page 12 of 50 4C). These results revealed that specific inhibition of CaM had significant effects on Na v 1.7 steady-state inactivation while having no effect on Na v 1.4 steady-state inactivation. by Na v 1.7 stimulated at high frequency (Fig. 5C ). Na v 1.7 stimulated at high frequency with the pipette solution alone showed a 16.6 ± 5.1 % (n = 5) decrease in current. This decrease was significantly smaller than the 32.4 ± 4.3 % (n = 5) decrease in current seen with 1 µM calmodulin inhibitory peptide in the pipette solution (Fig. 5C ). The usedependent effects of the CaM inhibitory peptide on Na v 1.7 and Na v 1.4, although significant, were not as large as the effects seen with TFP. This result, in conjunction with our observation that the calmodulin inhibitory peptide had no effect on Na v 1.4 steady-state inactivation, led us to hypothesize that the effects of TFP seen on these channels could be the result of something other than blocking CaM-channel interactions.
Calmodulin Inhibitory Peptide Shows Different Effects on
Page 13 of 50 13 TFP has a Higher Affinity for Inactivated Sodium Channels than for Resting Channels. As local anesthetics (LA) are known to exhibit use-dependent inhibition of sodium currents and induce a negative shift in the voltage-dependence of sodium channel steady-state inactivation, we hypothesized that TFP might be acting as a LA. According to the modulated receptor hypothesis of LA inhibition of sodium channels, the affinity of the LAs for sodium channels depends on the state of the channel, with inactivated channels exhibiting a much higher affinities than resting channels. We therefore tested the ability of 2 µM TFP to block Na v 1.7 and Na v 1.4 channels in the resting state by using a holding potential of -140 mV. Current was elicited with a pulse to 0 mV every 5 s and TFP caused a 8.3 ± 0.5 % (n = 10) and 8.4 ± 1.1% (n = 10) decrease in Na v 1.7 and Na v 1.4 current, respectively. This indicates that block of resting channels by TFP is similar for Na v 1.7 and Na v 1.4, with an estimated IC 50 of ~22 UM.To examine TFP binding to inactivated channels, cells were held at -120 mV and pre-pulsed to -60 mV for 10 seconds, pulsed to -120 mV for 50 ms to allow for recovery from fast inactivation, and then pulsed to 0 mV to elicit current. With this protocol, TFP caused a 85.6 ± 2.1 % (n = 5) and 87.4 ± 8.2% (n = 5) decrease in Na v 1.7 and Na v 1.4 current, respectively. This indicates that block of inactivated channels by TFP is also similar for Na v 1.7 and Na v 1.4, with an estimated IC 50 of ~300 nM. These data suggest that, like LA inhibition, TFP inhibition is state dependent. This also indicates that the disparity in block of Na v 1.7 and Na v 1.4 currents by 2 µM TFP observed in Figure 1 can be explained by differences in steady-state availability rather than differences in channel affinities for TFP.
TFP Increases the Onset of Inhibition and Slows Recovery from Inhibition
for Na v 1.7 and Na v 1.4. We further investigated the effect of TFP by examining the time Page 14 of 50 14 course for onset of inhibition and recovery from inhibition for Na v 1.7 and Na v 1.4 currents. Figure 6A (top) displays the protocol used to examine the onset of TFP inhibition for Na v 1.7 and Na v 1.4 currents. The onset of inhibition for Na v 1.7 and Na v 1.4 currents by 2 UM TFP was rapid compared to the development of slow inactivation observed under control conditions (Figure 6A bottom) . The time constants for the inhibition of Na v 1.7 and Na v 1.4 currents by 2 UM TFP were 49.1 ± 3.9 ms (n=13) and 62.6 ± 6.0 ms (n = 14), respectively and were not significantly different. The onset of Na v 1.7 and Na v 1.4 current inhibition by 500 nM TFP was significantly slower giving time constants of 148 ± 24 ms (n = 5) and 139 ± 26 ms (n = 5), respectively. Figure 6B displays the protocol used to examine the recovery from TFP inhibition for Na v 1.7 and Na v 1.4 currents. The recovery of Na v 1.7 currents from inhibition by 500 nM and 2 UM TFP (Fig. 6C, top) had time constants of 572 ± 36 Us (n = 6) and 686 ± 43 Us (n = 9), respectively. The recovery of Na v 1.4 currents from inhibition by 500 nM and 2 UM TFP (Fig. 6C, bottom) was slower with time constants of 1.0 ± 0.1 s (n = 5) and 1.2 ± 0.06 s (n = 10), respectively. TFP concentration did not have a significant effect on the time constants of recovery for either Na v 1.7 or Na v 1.4. This is consistent with the interaction seen between LAs and sodium channels in which drug unbinding rate was unrelated to drug concentration, indicating a simple bimolecular reaction of drug and channel (Bean et al., 1983) . To confirm that TFP was acting as a LA on Na v 1.7 or Na v 1.4, we tested the effects of TFP on Na v 1.4 channels that have mutations in their LA binding site. (Ragsdale, et al., 1994; Wright, et al., 1998; Li, et al., 1999; Nau, et al., 1999; Nau, et al., 2003) . Furthermore, it has been shown that the tricyclic antidepressant amitriptyline, which blocks voltage-gated sodium channels with a high degree of additional use-dependent block under repetitive pulses, also interacts with the LA binding site on sodium channels (Barber, et al., 1991; Nau, et al., 2000) . Three specific S6 residues located at DI, DIII, and DIV have been characterized as crucial for both LAs and amitriptyline binding in rat skeletal muscle (Na v 1.4) sodium channels (Wang, et al., 2004) . Lysine and arginine substitutions at residues N434 (DI-S6), L1280 (DIII-S6), and F1579 (DIV-S6) have been shown to reduce the affinity for both amitriptyline and LA binding to the inactivated state of the channel (Wang, et al., 2004; Nau and Wang, 2004) . In order to determine if TFP was acting through a possible LA mechanism, we applied TFP to rat Na v 1.4 channels having one of three amino acid substitutions (N434K, L1280K, F1579K) and looked for changes in effectiveness of TFP inhibition.
Since these LA binding-site mutations were performed with rat Na v 1.4, and the data shown in Figures 1-3 used human Na v 1.4, the control conditions involved application of TFP to wild-type rat Na v 1.4. Rat and human Na v 1.4 channels are highly conserved, and completely conserved in the CaM and LA binding site regions. Figure 7A displays the effects of application of 2 µM TFP to the external bath solution on sodium currents from the wild-type rat Na v 1.4 and the LA binding site mutant channels. The addition of 2 µM TFP to wild-type rat Na v 1.4 caused a decrease in peak sodium current Page 16 of 50 of 83.7 ± 2.6 % (n = 6; Fig. 7B) . Two of the LA binding site mutant channels, N434K
and F1579K, showed a significant attenuation in the decrease of peak sodium current caused by 2 µM TFP to 12.5 ± 1.8 % (n = 5) and 7.01 ± 3.2 % (n = 5), respectively. In contrast, the L1280K mutant channel showed a decrease of 80.3 ± 3.1 % (n = 5) in peak sodium current which was not significantly different from the decrease observed with the wild-type channel (Fig. 7B ).
As seen with human Na v 1.7 and Na v 1.4, TFP caused a significant hyperpolarizing shift in the V 1/2 of steady-state inactivation of rat Na v 1.4. Application of 2 µM TFP to rat Na v 1.4 caused a hyperpolarizing shift of -14.8 ± 1.1 mV (n = 6; Fig. 7C ). The N434K and F1579K mutant channels showed significantly smaller hyperpolarizing shifts in V 1/2 of steady-state inactivation in the presence of 2 µM TFP, having only shifts of -6.5 ± 1.1 mV (n = 5) and -5.0 ± 0.5 mV (n = 5), respectively (Fig. 7C) . The L1280K mutant channel in the presence of 2 µM TFP exhibited a hyperpolarizing shift of -14.6 ± 2.6 mV (n = 5; Fig. 7C ), which was not significantly different than that seen with the wild-type channel.
Use-dependent effects of TFP were also studied with the rat Na v 1.4 as well as with the LA binding-site mutant channels by using the same 5 Hz pulse protocol that was used with the human Na v 1.7 and Na v 1.4. Decreases in current evoked by the first pulse to current evoked by the last pulse of 84.6 ± 1.3% (n = 11) for the wild-type rat Na v 1.4 was observed in the presence of 2 µM TFP (Fig. 7D ). All three of the LA binding-site mutant channels showed significantly attenuated use-dependent decreases in current produced by high frequency stimulation in the presence of 2 µM TFP compared to the wild-type rat Na v 1.4 channel (Fig. 7D) . The decreases observed in the presence of 2 µM Page 17 of 50 TFP were 44.1 ± 1.7% (n = 5), 23.3 ± 5.4% (n = 5), and 35.2 ± 5.0% (n = 6) for LA binding-site mutant channels N434K, L1280K, and F1579K, respectively (Fig. 7D) .
However, the attenuated use-dependent decrease observed for the L1280K channel might not accurately reflect a decreased sensitivity of the channel to use-dependent inhibition brought on by TFP as 2 µM TFP decreased the steady-state L1280K current to the point at which additional use-dependent inhibition was difficult to determine. Therefore we also examined current produced from the LA binding-site mutant channels and the wildtype channel after high frequency stimulation in the presence of 500 nM TFP in an attempt to limit the initial effects on the L1280K channel. Our results show that 500 nM TFP produced a use-dependent decrease in current evoked by the first pulse to current evoked by the last pulse of 72.1 ± 2.7% (n = 8) for the wild-type rat Na v 1.4 channel. The decreases observed for LA binding-site mutant channels N434K, L1280K, and F1579K were 14.7 ± 2.2% (n = 6), 33.2 ± 3.8% (n = 6), and 15.1 ± 1.9% (n = 8), respectively. All of these observed use-dependent decreases were significantly attenuated compared to the use-dependent decreases seen with the wild-type rat Na v 1.4 channel.
Interestingly, the steady-state inactivation curves for each of the local anesthetic binding site mutant channels, in the absence of TFP, show that the N434K and F1579K mutations shifted steady-state inactivation of the channel in the depolarizing direction while the L1280K mutation shifted it in the hyperpolarizing direction compared to the wild-type channel (Fig. 8) . Therefore with a holding potential of -100 mV, more of the L1280K channels are in the inactivated state than the N434K or F1579K channels and this raises the possibility that the differential effect of TFP on the mutant channels could be influenced by the differential shifts in steady-state inactivation and may not reflect Page 18 of 50 differences in state-dependent binding. To address this we used protocols specifically designed to examine TFP binding to either the inactivated or closed state of the channels.
To examine TFP binding to the inactivated state of the channels, cells were held at -120 mV and pre-pulsed to -60 mV (wild-type, L1280K and F1579K channels) or -40 mV (N434K channels) for 10 seconds, pulsed to -120 mV for 100 ms to allow for recovery from fast inactivation, and then pulsed to 0 mV to elicit current. The steadystate inactivation curve for N434K and F1579K show a considerable amount of current available at -60 mV compared to WT channels (Fig. 8 ) and therefore to ensure that the mutant channels were inactivated to the same extent as WT channels, the cells expressing N434K and F1579K channels were pre-pulsed to -40 mV and -50 mV, respectively, instead of -60 mV. At -40 mV 96% of the N434K channels are inactivated, which is similar to the 97% of F1579K channels inactivated at -50 mV and 95% of WT channels inactivated at -60 mV. An initial current was measured in the absence of drug and a second current was measured in the presence of 500 nM TFP. After application of 500 nM TFP, only 21.9 ± 5.1% (n = 8) of the rat wild-type Na v 1.4 current remained (Fig 9A) .
The percentage of currents remaining for LA mutant channels N434K, L1280K, and F1579K after 500 nM TFP application were 75.9 ± 6.6% (n = 6), 33.3 ± 3.2% (n = 6), and 71.3 ± 10.3% (n = 6), respectively (Fig. 9A) . We used the percentage of remaining current to estimate the IC 50 for TFP by using the equation: (% remaining current)/((1-% remaining current) x [TFP]). The estimated IC 50 of TFP for the inactivated state of the rat wild-type Na v 1.4 channel is approximately 140 nM. The estimated IC 50 's for TFP on the inactivated state of the N434K, L1280K, and F1579K channels are approximately 1.6 µM, 250 nM, and 1.2 µM, respectively. Although all mutant channels had more peak Page 19 of 50 current remaining compared to the peak current remaining in the wild-type rat Na v 1.4, only the LA binding-site mutant channels N434K and F1579K showed a significance difference from the wild-type channel.
To examine TFP binding to the closed state of the channels, cells were pulsed to -140 mV for 10 seconds before pulsing to 0 mV to elicit a current. We were not able to see any significant changes in the percentage of remaining current from control conditions after application of 500 nM TFP. Therefore, we increased the concentration of TFP to 2 µM to see if we could observe differences in inhibition of channels in the closed state. After application of 2 µM TFP the wild-type rat Na v 1.4 had 93.0 ± 4.5% (n = 8) channel current remaining (Fig. 9B) and, based on this data, the estimated IC 50 of TFP for the closed state of the rat wild-type Na v 1.4 is approximately 27 µM. LA mutant channels N434K and F1579K after 2 µM TFP application had 103.9 ± 2.5% (n = 6) and 97.4 ± 3.8% (n = 8) of their current remaining, respectively, and these effects were not significantly different than those seen with the wild-type rat Na v 1.4 (Fig. 9B) . The L1280K mutant channel, however, showed a significant decrease in percent of remaining current in the presence of 2 µM TFP, with only 41.6 ± 3.3% (n = 5) remaining (Fig. 9B ).
The estimated IC 50 's for TFP on the closed state of the L1280K and F1579K channels are approximately 1.0 µM and 75 µM, respectively. The IC 50 for TFP on the closed state of the N434K mutant channel could not be estimated due to the amount of current remaining after TFP treatment being over 100%. However, it is probable that the IC 50 value is greater that 75 µM. Thus while the N434K and F1579K mutations reduced the apparent affinity of inactivated Na v 1.4 for TFP, the L1280K mutation increased the apparent affinity of Na v 1.4 in the closed state for TFP.
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To further investigate the possibility that these lysine substitutions directly affect TFP binding rather than indirectly attenuating TFP inhibition by altering the inactivation of the untreated channel, we examined the effects of TFP on the development of channel inhibition as well as on recovery from inhibition. Surprisingly, the N434K channels showed an enhanced (~ 2.5 x) development of inhibition by 2 UM TFP compared to WT channels while the F1579K channels showed a slower (~ 12 x) development of inhibition by 2 UM TFP (Table 1) . Based on the rates of channel inhibition by TFP observed for WT and N434K, channels, inactivating pre-pulses used for examining recovery from channel inhibition by TFP were set at 200 ms. However, based on the rate of channel inhibition, a 200 ms pre-pulse would not be long enough to allow for adequate drugbinding to F1579K channels, and therefore a 500 ms inactivating pre-pulse was used for examining recovery of F1579K from inhibition by TFP. Table 1 shows that the N434K and F1579K channels recover from 2 UM TFP inhibition approximately 4.5 and 3 times faster than do WT channels, respectively. These results indicate that while the N434K enhances the onset of TFP binding to inactivated Na v 1.4, the F1579K mutation attenuates the onset of TFP binding to the channel, and both mutations accelerate TFP unbinding from the inactivated Na v 1.4. These results strengthen the evidence that the differential effect of TFP on the mutant channels are due to differences in direct binding of the drug to the channel. Two-way ANOVA indicated overall group differences in duration of motor sciatic nerve block (Fig. 10A, F(4,35) = 110.38., P < 0.0001). Specific pairwise group comparisons with the post-hoc Tukey procedure revealed that the sciatic nerve blockade was significantly different for 80 mM vs. 40 mM TFP (P < 0.0001), 40 mM vs. 20 mM TFP (P < 0.0001), and 20 mM vs. 10 mM TFP (P = 0.024). In general, a highly significant dose-response relationship showed a less rapid return to baseline for the higher test doses. In addition, two-way ANOVA with repeated measures indicated that the blockade at test dose of 40 mM TFP was significantly different than using the same dose of lidocaine (P < 0.0001). Similarly, a two-way ANOVA indicated overall group differences in duration of sensory nerve block, (Fig. 10B, F(4,35) = 49.51, P < 0.0001).
Multiple pairwise group comparisons with the Tukey procedure revealed that the sensory blockade was significantly different for 80 mM vs. 40 mM TFP (P < 0.0001) and between 40 mM vs. 20 mM TFP (P = 0.001). No significant difference in sensory blockade duration was observed between 20 mM vs. 10 mM TFP (P = 0.57). ANOVA indicated that the sensory blockade at test dose of 40 mM TFP was also significantly different than using the same dose of lidocaine (P < 0.001).
Discussion
In this study, we investigated whether the calmodulin inhibitor TFP can modulate Na v 1.7 and Na v 1.4 channels. Although these channels may exhibit very different affinities for binding CaM (Herzog et al., 2003) , we show that TFP decreases current amplitude for both Na v 1.7 and Na v 1.4 and causes hyperpolarizing shifts in Na v 1.7 and Na v 1.4 steady-state inactivation while having no effect on the voltage-dependence of activation. We demonstrate that TFP has use-dependent inhibition effects on these channels and provide evidence that the predominant inhibitory effect of TFP is through binding to the LA binding site of these channels. Our data indicates that only a minor effect of TFP is likely due to preventing CaM interaction with the channels. We further reveal the mechanism of TFP inhibition by identifying specific amino acid residues that are involved in the binding of TFP to closed and inactivated Na v 1.4 channels. Finally, we showed that TFP can cause sensory and motor blockade in vivo after subfascial injection to rat sciatic nerve.
Our initial hypothesis for this work was that blocking CaM interactions with the IQ motif in the C-terminus of these channels by using TFP would influence the gating of the channels. However, the Na v 1.4 currents, which were dramatically inhibited by TFP, were largely unaffected by the specific CaM inhibitor, calmodulin inhibitory peptide, at high concentrations (1 µM; K D = 6 pM). The calmodulin inhibitory peptide did show significant effects on Na v 1.7 steady-state inactivation, but the use-dependent effects were much smaller than those induced by TFP. This indicated to us that, while CaM could play a role in regulating steady-state inactivation of Na v 1.7, the more profound effect of TFP on Na v 1.7 might be independent of CaM inhibition, suggesting that TFP altered Page 23 of 50 sodium currents through a different mechanism. Therefore, we investigated an alternative mechanism for the effects of TFP on Na v 1.7 and Na v 1.4.
Previous studies have reported that several phenothiazine neuroleptics that are structurally related to TFP can also block sodium currents in a use-dependent manner (Ogata, et al. 1990; Bolotina, et al. 1992; Liu, et al. 1992; Ahmmed, et al. 2002) .
However, the ability of TFP and these other neuroleptics to directly interact with sodium channels, and the molecular mechanism of this possible drug-channel interaction, has not previously been determined. LAs are known to produce hyperpolarizing shifts in steadystate inactivation and use-dependent inhibition of sodium currents by binding to a receptor site on the ion channel (Hille, 1977; Bean, et al., 1983) . These studies and our observations of TFP causing hyperpolarizing shifts in steady-state inactivation, exhibiting a higher apparent affinity for inactivated channels, and exhibiting a concentration independent recovery from inhibition led us to hypothesize that TFP might interact with Na v 1.7 and Na v 1.4 through the LA receptor. The attenuation of the inhibitory effects of TFP on the N434K and F1579K mutant channel currents indicates that these residues are important for the interaction of TFP with sodium channels and that TFP acts directly on the channel. Surprisingly, the inhibitory effects of TFP on L1280K mutant channel current were greater than (Fig 7A) or equal to (Fig. 7B ) the effects on wild-type Na v 1.4.
Although this is different from the effect that the L1280K mutation has on LA and amitriptyline binding, it is consistent with the hypothesis that the TFP binding site and the LA binding site overlap.
Our results show that TFP preferentially binds to the inactivated state of voltagegated sodium channels compared to the closed state. The N434K and F1579K mutant Page 24 of 50 24 Na v 1.4 channels showed a significantly decreased mean response to 500 nM TFP in their inactivated state indicating that the binding of TFP to the channel is reliant on these 2 residues when the channel is inactivated. Interestingly, the L1280K channel showed no significant difference in the apparent affinity of the inactivated state. However, inhibition of the L1280K channel in the closed state was potentiated compared to that of the wildtype, N434K, and F1579K channels. This result indicates that the L1280K mutation enhances the binding of TFP to the closed-state of the channel. Overall, our data shows that Na v 1.4 in its inactivated state has a higher affinity for TFP and the N434 and F1579 residues are important for efficient binding of TFP to the inactivated state of the sodium channel. Furthermore, these results show that the L1280 residue has less involvement in the binding of TFP to the inactivated state of the channel than residues N434 and F1579.
However, these results also show that out of the N434, L1280, and F1579 residues, only the L1280 residue is important for TFP binding to the closed-state of voltage-gated sodium channels.
Due to conserved homology between the Na v 1.4 and Na v 1.7 LA binding site, we hypothesize that the inhibitory effects of TFP on human Na v 1.7 are due to direct interaction with this site. Sciatic nerve block was chosen to examine in vivo effects as TFP given intrathecally cannot be extrapolated to provide analgesia (and anesthesia) in peripheral nerves due to peripheral nerves nerve fibers being myelinated and embedded in multiple layers of relatively thick nerve sheaths. Our data suggest that the direct interaction with neuronal sodium channels could help explain the finding that TFP injections in sciatic nerve produces motor and sensory blockade. The nerve block by Page 25 of 50 25 TFP was found to be robust and more potent than lidocaine suggesting that TFP or TFP analogs might be useful for inducing prolonged nerve block.
Overall, our experiments show that the inhibition of sodium current caused by the CaM inhibitor TFP is largely independent of the inhibition of CaM interactions. The majority of the inhibition by TFP can be attributed to direct interaction of the drug with the sodium channels in a state-dependent manner. Interestingly, TFP's label as a potent CaM inhibitor has resulted in its effects being commonly related to inhibition of the calmodulin/CaMKII pathway. Studies using TFP to inhibit CaM and its effectors could be overlooking the direct action of TFP on sodium channels. This inhibitory action might lead to inaccurate conclusions regarding CaM's involvement in physiological processes.
More specifically, studies correlating CaM inhibition with nerve block using TFP could be demonstrating a direct interaction of the drug with the voltage-gated sodium channels that are highly expressed in peripheral nerves. The ability of TFP to block Na v 1.7 at low doses could make it a potential therapeutic regimen for regional anesthesia and pain management that would be more potent than traditional local anesthetics. TFP. Cells containing the channels were held at -100 mV and stepped to an inactivating pre-pulse (-130 to 40 mV) for 500 ms. The channels that remain available after each inactivating pre-pulse were assessed by the peak current produced during a test pulse to -10 mV for 25 ms. A and B, 500 nM (A) and 2 µM TFP(B) caused hyperpolarizing shifts in steady-state inactivation curves of Na v 1.7 channels. The average value of V 1/2 of inactivation under control conditions for Na v 1.7 channels was -83.9 ± 1.5 mV which was averaged from experiments in A and B. C, TFP and time caused hyperpolarizing shifts (mV) in V 1/2 of inactivation for Na v 1.7 channels. TFP at a concentration of 2 µM in the external bath solution was the only condition to cause a significant shift in V 1/2 of inactivation compared to the time-dependent control. D and E, 500 nM (D) and 2 µM TFP (E) caused hyperpolarizing shifts in steady-state inactivation curves of Na v 1.4
Page 34 of 50 channels. The average value of V 1/2 of inactivation under control conditions for Na v 1.4 channels was -74.8 ± 2.0 mV which was averaged from experiments in D and E. F, TFP and time also caused hyperpolarizing shifts (mV) in V 1/2 of inactivation for Na v 1.7 channels. Statistical significance was determined using a Student's paired t test (* = p <0.05, ** = p < 0.01). stepped to an inactivating pre-pulse (-130 to 40 mV) for 200 ms. The channels that remain available after each inactivating pre-pulse were assessed by the peak current produced during a test pulse to -10 mV for 25 ms. A, Steady-state inactivation curves for Na v .1.7 current with (n = 5) and without (n = 5) 1 µM calmodulin inhibitory peptide. B, Steady-state inactivation curves for Na v 1.4 current with and without 1 µM calmodulin inhibitory peptide. C, 1 µM calmodulin inhibitory peptide causes a significant hyperpolarizing shift in the V 1/2 of steady-state inactivation for the Na v 1.7 channel. 1 µM calmodulin inhibitory peptide had no significant effects on the V 1/2 of steady-state inactivation for the Na v 1.4 channel. Statistical significance was determined using a Student's unpaired t test (* = p <0.05, ** = p < 0.01). comparison of effects of 2 µM TFP on the rat Na v 1.4 channels and rat LA mutant channels shows that the LA mutant channels, N434K and F1579K, displayed a significant reduction in % decrease of peak current. The protocol for C is described in the Figure 2 legend. C, shift in steady-state inactivation of rat Na v 1.4 channels and rat LA mutant Na v 1.4 channels, N434K, L1280K, F1579K in the presence of TFP. D, use-dependent block of the rat Na v 1.4 channels and rat LA mutant Na v 1.4 channels, N434K, L1280K, F1579K in the presence of 500 nM or 2 µM TFP. High frequency stimulation followed the same protocol as shown in Fig. 3 . Statistical significance was determined using a Page 37 of 50 one-way ANOVA analysis followed with a Tukey's comparison test (* = p < 0.05, *** = p < 0.001). Fig. 8 . Steady-state inactivation curves of the rat wild-type (n = 11) and LA mutant channels, N434K (n = 10), L1280K (n = 9), F1579K (n = 10).
Fig 9.
State-dependent effects of 500 nM TFP on the rat wild-type and LA mutant channels, N434K, L1280K, F1579K. A, percentage of control current remaining after application of 500 nM TFP to rat wild-type and LA mutant channels in their inactivated state. For the N434K channel, the pre-pulse voltage was -40 mV to ensure inactivation of the channels. B, Percentage of control current remaining after application of 2 µM TFP to rat wild-type and LA mutant channels in their closed state. Statistical significance was determined using one-way ANOVA analysis followed with a Tukey's comparison test (** = p < 0.01, *** = p < 0.001). 
